Literature DB >> 20216278

Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer.

Jong Ha Hwang1, Seung Hun Song, Jae Kwan Lee, Nak Woo Lee, Kyu Wan Lee.   

Abstract

OBJECTIVE: The aim of this study was to examine the bone mineral density (BMD) of women with cervical cancer treated with chemoradiation and to compare the outcomes with those of women with myomas treated by hysterectomy.
METHODS: The BMDs of 43 women with cervical cancer treated with concurrent chemoradiation (CCRT) were measured by dual-energy x-ray absorptiometry (L-spine and proximal femur) and compared with those of 43 matched control women with the same age distribution and body mass index. Medical records were reviewed retrospectively. Both women with cervical cancer and control women had reached menopause or had a history of bilateral salpingo-oophorectomy.
RESULTS: The lowest T scores for BMD were significantly lower in the women with cervical cancer treated with CCRT compared with the control women (P = 0.017). The serum total alkaline phosphatase was significantly higher in women with cervical cancer treated with CCRT (P = 0.027). There was no correlation between total alkaline phosphatase and BMD (L-spine and proximal femur; r = 0.089, P = 0.416). The BMDs of both the greater trochanter of the femur (P = 0.013) and L4 (P = 0.011) were significantly lower in women with cervical cancer than in the control women.
CONCLUSIONS: The results of this study suggest that postmenopausal women with uterine cervical cancer treated with CCRT have a lower BMD and are at risk for osteoporosis.

Entities:  

Mesh:

Year:  2010        PMID: 20216278     DOI: 10.1097/gme.0b013e3181b9b11f

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  7 in total

1.  Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data.

Authors:  Hyo Geun Choi; Jung Woo Lee; Chan Yang Min; Dae Myoung Yoo; Suk Woo Lee
Journal:  Int J Clin Oncol       Date:  2021-06-06       Impact factor: 3.402

Review 2.  Prevention and treatment of bone fragility in cancer patient.

Authors:  Silva Ottanelli
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

3.  Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL.

Authors:  Tapasi Rana; Michelle A Schultz; Michael L Freeman; Swati Biswas
Journal:  Free Radic Biol Med       Date:  2012-10-22       Impact factor: 7.376

4.  Bone Density in Patients with Cervical Cancer or Endometrial Cancer in comparison with Healthy Control; According to the stages.

Authors:  Yubin Lee; Ari Kim; Heung Yeol Kim; Wan Kyu Eo; Eun Sil Lee; Sungwook Chun
Journal:  J Cancer       Date:  2015-06-10       Impact factor: 4.207

5.  Changes in bone density after cancer treatment in patients with cervical and endometrial cancer.

Authors:  Young Lim Oh; Man Soo Yoon; Dong Soo Suh; Ari Kim; Min Joung Kim; Ji Young Lee; Yong Jung Song; Yong Il Ji; Ki Hyung Kim; Sungwook Chun
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

6.  Indirect effects of X-irradiation on proliferation and osteogenic potential of bone marrow mesenchymal stem cells in a local irradiated rat model.

Authors:  Ruilian Sun; Guoying Zhu; Jianping Wang; Ling Tong; Jianglong Zhai
Journal:  Mol Med Rep       Date:  2017-04-12       Impact factor: 2.952

7.  Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women.

Authors:  Keina Nishio; Akiko Tanabe; Risa Maruoka; Kiyoko Nakamura; Masaaki Takai; Tatsuharu Sekijima; Satoshi Tunetoh; Yoshito Terai; Masahide Ohmichi
Journal:  Endocr Connect       Date:  2012-11-19       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.